English

SIGHT SCIENCES, INC.

EDGAR

SGHT Quarterly report (10-Q) · filed 2026-08-05

Annual consolidated revenue for 2025: about USD 77.36M, using the latest reported figures. The previous period, 2024, was about USD 79.87M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

23.4 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 23388000 USD Source

Operating margin

-16.62%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -3888000 USD Source
Revenue: 23388000 USD Source

Operating cash flow

-5.66 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -12692000 USD Source
Operating Cash Flow: -7029000 USD Source

Free cash flow

-5.68 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -12692000 USD Source
Operating Cash Flow: -7029000 USD Source
Capital Expenditure: 79000 USD Source
Capital Expenditure: 60000 USD Source

Cash and cash equivalents: 79.8 million USD 2026-06-30 Source
Exact value

79753000 USD
Long-term debt including current maturities: 42.4 million USD 2026-03-31 Source
Exact value

42380000 USD
Shares outstanding: 54.7 million shares 2026-06-30 Source
Exact value

54716301 shares

Reported share-count change

5.16% · 2.68 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

52033403 shares · 2025-06-30· Source
54716301 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

83.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 19906000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 77363000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 56978000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 19698000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 23388000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-29.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -8169000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -38426000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -34264000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -12980000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -4446000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-23.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -27867000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -19148000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -29694000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -27867000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -7029000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -12692000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -7029000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2025-12-31
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-3.1%

Prior period

USD 79.87 million

2024-01-01 – 2024-12-31
Current period

USD 77.36 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

77363000 − 79866000 = -2503000 USD

79866000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
77363000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Year-over-year change in Revenue: -2503000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 77363000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2647064 Filing: 000119312526091558 Input fundies:Revenue: 79866000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2648724 Filing: 000119312526091558
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 13.08 million

Prior period

−USD 51.51 million

2024-01-01 – 2024-12-31
Current period

−USD 38.43 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-38426000 − -51507000 = 13081000 USD

-51507000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-38426000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Year-over-year change in Net income: 13081000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -38426000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2385566 Filing: 000119312526091558 Input fundies:NetIncome: -51507000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2387289 Filing: 000119312526091558
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 7.34 million

Prior period

−USD 22.35 million

2024-01-01 – 2024-12-31
Current period

−USD 29.69 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-29694000 − -22351000 = -7343000 USD

-22351000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-29694000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Year-over-year change in Operating cash flow: -7343000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -29694000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1648584 Filing: 000119312526091558 Input fundies:OperatingCashFlow: -22351000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1650464 Filing: 000119312526091558
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-41.8%

Prior period

USD 385,000

2024-01-01 – 2024-12-31
Current period

USD 224,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

224000 − 385000 = -161000 USD

385000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
224000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Year-over-year change in Capital expenditure: -161000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 224000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1655333 Filing: 000119312526091558 Input fundies:CapitalExpenditure: 385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1657201 Filing: 000119312526091558
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 77.36 million 100% of revenue
Cost of revenue USD 10.7 million 14% of revenue
Operating expenses USD 103.77 million 134% of revenue
Operating income −USD 37.1 million −48% of revenue
Tax, interest and other Derived USD 1.33 million 1.7% of revenue
Net income −USD 38.43 million −50% of revenue

Cash

Operating cash flow −USD 29.69 million −38% of revenue
Capital expenditure USD 224,000 0.3% of revenue
Free cash flow Derived −USD 29.92 million −39% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 216% of revenue.
2021 Operating loss: operating costs were 205% of revenue.
2022 Operating loss: operating costs were 218% of revenue.
2023 Operating loss: operating costs were 171% of revenue.
2024 Operating loss: operating costs were 163% of revenue.
2025 Operating loss: operating costs were 148% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	27640000	59828000 Derived	-32188000	2505000 Derived	-34693000	-33127000 Derived	Source 2020-01-01 – 2020-12-31: 27640000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -32188000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -34693000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -32174000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 953000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	48956000	100434000 Derived	-51478000	11482000 Derived	-62960000	-53353000 Derived	Source 2021-01-01 – 2021-12-31: 48956000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -51478000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -62960000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -52540000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 813000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	71331000	155285000 Derived	-83954000	2288000 Derived	-86242000	-76935000 Derived	Source 2022-01-01 – 2022-12-31: 71331000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -83954000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -86242000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -75965000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 970000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	81056000	138330000 Derived	-57274000	-1727000 Derived	-55547000	-47975000 Derived	Source 2023-01-01 – 2023-12-31: 81056000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -57274000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -55547000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -47184000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 791000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	79866000	130398000 Derived	-50532000	975000 Derived	-51507000	-22736000 Derived	Source 2024-01-01 – 2024-12-31: 79866000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -50532000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -51507000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -22351000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 385000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	77363000	114462000 Derived	-37099000	1327000 Derived	-38426000	-29918000 Derived	Source 2025-01-01 – 2025-12-31: 77363000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -37099000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -38426000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -29694000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 224000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 77.4M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	27640000	Revenue: 27640000 Open source
20212021-12-31	Revenue	48956000	Revenue: 48956000 Open source
20222022-12-31	Revenue	71331000	Revenue: 71331000 Open source
20232023-12-31	Revenue	81056000	Revenue: 81056000 Open source
20242024-12-31	Revenue	79866000	Revenue: 79866000 Open source
20252025-12-31	Revenue	77363000	Revenue: 77363000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-3.1% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 27640000 Open source
20212021-12-31	Year over year	77.1%	Revenue: 48956000 Open source Revenue: 27640000 Open source
20222022-12-31	Year over year	45.7%	Revenue: 71331000 Open source Revenue: 48956000 Open source
20232023-12-31	Year over year	13.6%	Revenue: 81056000 Open source Revenue: 71331000 Open source
20242024-12-31	Year over year	-1.5%	Revenue: 79866000 Open source Revenue: 81056000 Open source
20252025-12-31	Year over year	-3.1%	Revenue: 77363000 Open source Revenue: 79866000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -48% 2025

Net margin -49.7% 2025

Free cash flow margin -38.7% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-116.5%	Operating Income: -32188000 Open source Revenue: 27640000 Open source
20212021-12-31	Operating margin	-105.2%	Operating Income: -51478000 Open source Revenue: 48956000 Open source
20222022-12-31	Operating margin	-117.7%	Operating Income: -83954000 Open source Revenue: 71331000 Open source
20232023-12-31	Operating margin	-70.7%	Operating Income: -57274000 Open source Revenue: 81056000 Open source
20242024-12-31	Operating margin	-63.3%	Operating Income: -50532000 Open source Revenue: 79866000 Open source
20252025-12-31	Operating margin	-48%	Operating Income: -37099000 Open source Revenue: 77363000 Open source
20202020-12-31	Net margin	-125.5%	Net Income: -34693000 Open source Revenue: 27640000 Open source
20212021-12-31	Net margin	-128.6%	Net Income: -62960000 Open source Revenue: 48956000 Open source
20222022-12-31	Net margin	-120.9%	Net Income: -86242000 Open source Revenue: 71331000 Open source
20232023-12-31	Net margin	-68.5%	Net Income: -55547000 Open source Revenue: 81056000 Open source
20242024-12-31	Net margin	-64.5%	Net Income: -51507000 Open source Revenue: 79866000 Open source
20252025-12-31	Net margin	-49.7%	Net Income: -38426000 Open source Revenue: 77363000 Open source
20202020-12-31	Free cash flow margin	-119.9%	Revenue: 27640000 Open source Operating Cash Flow: -32174000 Open source Capital Expenditure: 953000 Open source
20212021-12-31	Free cash flow margin	-109%	Revenue: 48956000 Open source Operating Cash Flow: -52540000 Open source Capital Expenditure: 813000 Open source
20222022-12-31	Free cash flow margin	-107.9%	Revenue: 71331000 Open source Operating Cash Flow: -75965000 Open source Capital Expenditure: 970000 Open source
20232023-12-31	Free cash flow margin	-59.2%	Revenue: 81056000 Open source Operating Cash Flow: -47184000 Open source Capital Expenditure: 791000 Open source
20242024-12-31	Free cash flow margin	-28.5%	Revenue: 79866000 Open source Operating Cash Flow: -22351000 Open source Capital Expenditure: 385000 Open source
20252025-12-31	Free cash flow margin	-38.7%	Revenue: 77363000 Open source Operating Cash Flow: -29694000 Open source Capital Expenditure: 224000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -29.7M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-32174000	Operating Cash Flow: -32174000 Open source
20212021-12-31	Operating cash flow	-52540000	Operating Cash Flow: -52540000 Open source
20222022-12-31	Operating cash flow	-75965000	Operating Cash Flow: -75965000 Open source
20232023-12-31	Operating cash flow	-47184000	Operating Cash Flow: -47184000 Open source
20242024-12-31	Operating cash flow	-22351000	Operating Cash Flow: -22351000 Open source
20252025-12-31	Operating cash flow	-29694000	Operating Cash Flow: -29694000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -29.9M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-33127000	Operating Cash Flow: -32174000 Open source Capital Expenditure: 953000 Open source
20212021-12-31	Free cash flow	-53353000	Operating Cash Flow: -52540000 Open source Capital Expenditure: 813000 Open source
20222022-12-31	Free cash flow	-76935000	Operating Cash Flow: -75965000 Open source Capital Expenditure: 970000 Open source
20232023-12-31	Free cash flow	-47975000	Operating Cash Flow: -47184000 Open source Capital Expenditure: 791000 Open source
20242024-12-31	Free cash flow	-22736000	Operating Cash Flow: -22351000 Open source Capital Expenditure: 385000 Open source
20252025-12-31	Free cash flow	-29918000	Operating Cash Flow: -29694000 Open source Capital Expenditure: 224000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

44.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	60.9%	Total Liabilities: 44324000 Open source Total Assets: 72806000 Open source
20212021-12-31	Liabilities / assets	17.2%	Total Liabilities: 48079000 Open source Total Assets: 280186000 Open source
20222022-12-31	Liabilities / assets	24.9%	Total Liabilities: 52997000 Open source Total Assets: 213073000 Open source
20232023-12-31	Liabilities / assets	27.9%	Total Liabilities: 46436000 Open source Total Assets: 166651000 Open source
20242024-12-31	Liabilities / assets	38.7%	Total Liabilities: 55316000 Open source Total Assets: 142839000 Open source
20252025-12-31	Liabilities / assets	44.5%	Total Liabilities: 51358000 Open source Total Assets: 115300000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

10.22× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	7.58×	Current Assets: 70633000 Open source Current Liabilities: 9314000 Open source
20212021-12-31	Current assets / current liabilities	20.52×	Current Assets: 277035000 Open source Current Liabilities: 13504000 Open source
20222022-12-31	Current assets / current liabilities	11.77×	Current Assets: 209677000 Open source Current Liabilities: 17817000 Open source
20232023-12-31	Current assets / current liabilities	13.29×	Current Assets: 162871000 Open source Current Liabilities: 12252000 Open source
20242024-12-31	Current assets / current liabilities	9.04×	Current Assets: 139774000 Open source Current Liabilities: 15468000 Open source
20252025-12-31	Current assets / current liabilities	10.22×	Current Assets: 112734000 Open source Current Liabilities: 11027000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 34.69 million Exact value Exact value: -34693000 USD 2020-01-01 – 2020-12-31: -34693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2020-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -34693000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34693000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017022004563/sght-20211231.htm#2924659 Filing: 000095017022004563 The citation records this snapshot. The page link may show a newer release later.	−USD 32.17 million Exact value Exact value: -32174000 USD 2020-01-01 – 2020-12-31: -32174000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2020-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -32174000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32174000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017022004563/sght-20211231.htm#2097437 Filing: 000095017022004563 The citation records this snapshot. The page link may show a newer release later.	USD 953,000 Exact value Exact value: 953000 USD 2020-01-01 – 2020-12-31: 953000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2020-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 953000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 953000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017022004563/sght-20211231.htm#2104771 Filing: 000095017022004563 The citation records this snapshot. The page link may show a newer release later.	−USD 33.13 million Calculation and evidence -32174000 − 953000 USD Exact free cash flow: -33127000 USD 2020-01-01 – 2020-12-31: -32174000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 953000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2020-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -33127000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32174000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017022004563/sght-20211231.htm#2097437 Filing: 000095017022004563 Input fundies:CapitalExpenditure: 953000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017022004563/sght-20211231.htm#2104771 Filing: 000095017022004563 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 62.96 million Exact value Exact value: -62960000 USD 2021-01-01 – 2021-12-31: -62960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2021-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -62960000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62960000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017023008526/sght-20221231.htm#2450846 Filing: 000095017023008526 The citation records this snapshot. The page link may show a newer release later.	−USD 52.54 million Exact value Exact value: -52540000 USD 2021-01-01 – 2021-12-31: -52540000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2021-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -52540000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -52540000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017023008526/sght-20221231.htm#1757321 Filing: 000095017023008526 The citation records this snapshot. The page link may show a newer release later.	USD 813,000 Exact value Exact value: 813000 USD 2021-01-01 – 2021-12-31: 813000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2021-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 813000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 813000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017023008526/sght-20221231.htm#1765445 Filing: 000095017023008526 The citation records this snapshot. The page link may show a newer release later.	−USD 53.35 million Calculation and evidence -52540000 − 813000 USD Exact free cash flow: -53353000 USD 2021-01-01 – 2021-12-31: -52540000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 813000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2021-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -53353000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52540000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017023008526/sght-20221231.htm#1757321 Filing: 000095017023008526 Input fundies:CapitalExpenditure: 813000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017023008526/sght-20221231.htm#1765445 Filing: 000095017023008526 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 86.24 million Exact value Exact value: -86242000 USD 2022-01-01 – 2022-12-31: -86242000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2022-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -86242000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -86242000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017024030278/sght-20231231.htm#1801428 Filing: 000095017024030278 The citation records this snapshot. The page link may show a newer release later.	−USD 75.97 million Exact value Exact value: -75965000 USD 2022-01-01 – 2022-12-31: -75965000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2022-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -75965000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -75965000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017024030278/sght-20231231.htm#1313610 Filing: 000095017024030278 The citation records this snapshot. The page link may show a newer release later.	USD 970,000 Exact value Exact value: 970000 USD 2022-01-01 – 2022-12-31: 970000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2022-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 970000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 970000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017024030278/sght-20231231.htm#1318627 Filing: 000095017024030278 The citation records this snapshot. The page link may show a newer release later.	−USD 76.94 million Calculation and evidence -75965000 − 970000 USD Exact free cash flow: -76935000 USD 2022-01-01 – 2022-12-31: -75965000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 970000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2022-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -76935000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -75965000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017024030278/sght-20231231.htm#1313610 Filing: 000095017024030278 Input fundies:CapitalExpenditure: 970000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017024030278/sght-20231231.htm#1318627 Filing: 000095017024030278 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 55.55 million Exact value Exact value: -55547000 USD 2023-01-01 – 2023-12-31: -55547000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2023-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -55547000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55547000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017025035500/sght-20241231.htm#2192534 Filing: 000095017025035500 The citation records this snapshot. The page link may show a newer release later.	−USD 47.18 million Exact value Exact value: -47184000 USD 2023-01-01 – 2023-12-31: -47184000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2023-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -47184000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47184000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017025035500/sght-20241231.htm#1592614 Filing: 000095017025035500 The citation records this snapshot. The page link may show a newer release later.	USD 791,000 Exact value Exact value: 791000 USD 2023-01-01 – 2023-12-31: 791000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2023-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 791000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 791000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017025035500/sght-20241231.htm#1598899 Filing: 000095017025035500 The citation records this snapshot. The page link may show a newer release later.	−USD 47.98 million Calculation and evidence -47184000 − 791000 USD Exact free cash flow: -47975000 USD 2023-01-01 – 2023-12-31: -47184000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 791000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2023-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -47975000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47184000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017025035500/sght-20241231.htm#1592614 Filing: 000095017025035500 Input fundies:CapitalExpenditure: 791000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000095017025035500/sght-20241231.htm#1598899 Filing: 000095017025035500 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 51.51 million Exact value Exact value: -51507000 USD 2024-01-01 – 2024-12-31: -51507000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2024-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -51507000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51507000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2387289 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	−USD 22.35 million Exact value Exact value: -22351000 USD 2024-01-01 – 2024-12-31: -22351000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2024-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -22351000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22351000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1650464 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	USD 385,000 Exact value Exact value: 385000 USD 2024-01-01 – 2024-12-31: 385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2024-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 385000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1657201 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	−USD 22.74 million Calculation and evidence -22351000 − 385000 USD Exact free cash flow: -22736000 USD 2024-01-01 – 2024-12-31: -22351000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2024-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -22736000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22351000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1650464 Filing: 000119312526091558 Input fundies:CapitalExpenditure: 385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1657201 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 38.43 million Exact value Exact value: -38426000 USD 2025-01-01 – 2025-12-31: -38426000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Net Income: -38426000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38426000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#2385566 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	−USD 29.69 million Exact value Exact value: -29694000 USD 2025-01-01 – 2025-12-31: -29694000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Operating Cash Flow: -29694000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29694000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1648584 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	USD 224,000 Exact value Exact value: 224000 USD 2025-01-01 – 2025-12-31: 224000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Capital Expenditure: 224000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 224000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1655333 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.	−USD 29.92 million Calculation and evidence -29694000 − 224000 USD Exact free cash flow: -29918000 USD 2025-01-01 – 2025-12-31: -29694000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 224000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGHT SCIENCES, INC. · 2025-12-31 SIGHT SCIENCES, INC. (edgar:1531177) Free cash flow: -29918000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531177?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29694000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1648584 Filing: 000119312526091558 Input fundies:CapitalExpenditure: 224000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531177/000119312526091558/sght-20251231.htm#1655333 Filing: 000119312526091558 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 2,274 latest values · 2,274 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001531177, 1531177, SGHT, edgar:1531177

Also known as SIGHT SCIENCES, INC., Sight Sciences, Inc.

SIGHT SCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation